SCHEMBL11941207

SCHEMBL11941207

c1ccc2cc(-c3c4ccccc4c(-c4ccc5ccccc5c4)c4cc(-c5ccc(-c6nccc7c6sc6ccccc67)cc5)ccc34)ccc2c1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR2B P41595 2/20 0.44
HTR5A P47898 2/20 0.44
LIMK1 P53667 2/20 0.34
ALOX5 P09917 1/20 0.33
ROCK1 Q13464 1/20 0.33
MAPK9 P45984 2/20 0.33
MAPK10 P53779 2/20 0.33
MAPT P10636 2/20 0.33
MAPK8 P45983 1/20 0.33
CYP17A1 P05093 1/20 0.33
CYP19A1 P11511 1/20 0.33
CYP11B1 P15538 1/20 0.33
CYP11B2 P19099 1/20 0.33
ESR1 P03372 1/20 0.33
ESR2 Q92731 1/20 0.33
GSK3B P49841 1/20 0.31
ADORA2A P29274 1/20 0.31
ADORA1 P30542 1/20 0.31
MAPKAPK2 P49137 1/20 0.31
PDE3B Q13370 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11941212 0.97 HTR2B (0.44) HTR2BHTR5ALIMK1ALOX5ROCK1
SCHEMBL30606988 0.95 HTR2B (0.45) HTR2BHTR5ALIMK1ALOX5MAPK9
SCHEMBL11030653 0.95 HTR2B (0.45) HTR2BHTR5ALIMK1ALOX5MAPK9
SCHEMBL11941218 0.93 HTR2B (0.44) HTR2BHTR5AALOX5MAPK9MAPK10
SCHEMBL11941217 0.89 HTR2B (0.45) HTR2BHTR5AALOX5MAPK9MAPK10
SCHEMBL20909409 0.89 HTR2B (0.41) HTR2BHTR5AALOX5MAPK9MAPK10
SCHEMBL11941211 0.89 HTR2B (0.40) HTR2BHTR5AALOX5MAPK9MAPK10
SCHEMBL11941215 0.88 HTR2B (0.40) HTR2BHTR5AALOX5MAPK9MAPK10
SCHEMBL11941208 0.88 HTR2B (0.38) HTR2BHTR5AALOX5MAPK9MAPK10
SCHEMBL25830815 0.86 HTR2B (0.40) HTR2BHTR5AALOX5MAPK9MAPK10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8415031-B2 Electron transporting compounds UNIVERSAL DISPLAY CORPORATION (US) 2013-04-09 US disclosed
US-8415031-B2 Electron transporting compounds UNIVERSAL DISPLAY CORPORATION (US) 2013-04-09 US disclosed
US-20120187381-A1 Electron Transporting Compounds UNIVERSAL DISPLAY CORPORATION (US) 2012-07-26 US disclosed
US-20120187381-A1 Electron Transporting Compounds UNIVERSAL DISPLAY CORPORATION (US) 2012-07-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120187381-A1 Electron Transporting Compounds SLC19A2, ABCB7, SLCO2B1 HTR2B 2238/4885HTR5A 3346/4885LIMK1 4565/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.